Latest Strategy News

Aquirian Limited reports a robust first half of FY26 with revenue up 27.4% and EBITDA more than doubling, driven by strategic facility upgrades and promising joint ventures.

Osteopore Limited has completed the full subscription of Tranche 1 under its A$20 million convertible notes facility, raising an additional A$250,000 to support ongoing business and future projects.

Metgasco shareholders have approved the sale of their 25% stake in the Southern Flank joint ventures to Vintage Energy, marking a key milestone in Vintage’s strategic expansion. The deal still awaits final conditions before completion.

Oliver’s Real Food reported a remarkable 1926% increase in EBIT to $527k for the December 2025 quarter, despite a 7.7% revenue decline driven by strategic store closures. Same-store sales rose nearly 6%, underpinning a cautiously optimistic outlook.

Imperial Pacific reports a robust 17% increase in portfolio value for the half year ending December 2025, driven by gains in London City’s holdings and the strategic liquidation of Excelsior Capital. The company also paid a fully franked 7 cent dividend, signalling confidence despite pending audit reviews.

Eagle Mountain Mining has closed its entitlement offer, raising just over half of its targeted $1.98 million, with a significant shortfall to be placed alongside lead managers. The funds will support its copper-gold exploration projects in Arizona.

Atomic Eagle Limited has completed a 69-hole drilling program at its Chisebuka target in Zambia, revealing extensive shallow uranium mineralisation and setting the stage for a major resource upgrade across the Muntanga Project.

Neuren Pharmaceuticals’ partner Acadia projects DAYBUE sales to reach around US$700 million by 2028, driven by US market expansion and international approvals. The launch of a new formulation and ongoing clinical trials in Japan underpin this optimistic outlook.

betr Entertainment has reported a robust 24.5% increase in turnover for Q2 FY26 alongside a strategic on-market share buy-back of up to 10%, signalling confidence in its intrinsic value and growth prospects.

Little Green Pharma Ltd has agreed to acquire Cannatrek Ltd in a transformational merger that will create a leading vertically integrated medicinal cannabis group across Australia and Europe. The deal combines cultivation, manufacturing, distribution, clinics, and digital health platforms under one roof, positioning the combined entity for accelerated growth.

Stavely Minerals has initiated an updated 2026 Scoping Study for its copper-gold project in Western Victoria, driven by significantly higher metal prices and improved economic prospects since 2022.

HighCom Limited appoints seasoned executive Geoffrey Knox as Executive Chairman and CEO, signaling a strategic push to strengthen its defence manufacturing and sustainment operations in Australia and the US.